Pfizer’s talks to acquire Allergan in a $150 billion deal
Pfizer’s talks to acquire Allergan in a $150 billion deal that would see the US drug giant redomicile in Ireland accelerated on Wednesday, as the US Treasury prepared to clamp down further on such tax More...
Teva bid for Mylan could come today – Bloomberg
Bloomberg reports that Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) could publish a bid for its US rival Mylan Inc. (MYL) today, in what could turn out to be the largest deal of the year in More...
Israel Gives Oramed New Patent for Oral Administrations of Exenatide
The Israel Patent Office has granted Israel’s Oramed Pharmaceuticals, a developer of oral drug delivery systems, a patent for its invention, titled “Methods and Compositions for Oral Administrations More...
Teva launches generic blood pressure treatment in US
– Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has announced : the Food and Drug Administration (FDA) approval and the launch of the generic equivalent of Diovan (Valsartan) tablets in More...
Biotech Company Juno Therapeutics Possibly on George Soros’ Radar
Billionaire investor George Soros may have an interest in Juno Therapeutics, an immunotherapy stock that had its IPO last Friday, multimedia financial services company The Motley Fool said. As of the end More...
Israeli Marijuana Companies Smoking Up Wall Street
Originally published by The Jewish Press. The Israeli-bases One World Cannabis (OWC) company is going to be traded over the counter on Wall Street after the Dynamic Applications merges with it, Globes business More...
George Soros Dumps Biotech
– The biotech sector has been outperforming the S&P 500, and some money managers continue to buy even as others are concerned about a bubble, as reported by Motley Fool. The iShares More...
Exclusive: Valeant to drop deal-making in near term to cut debt, boost stock
– Valeant Pharmaceuticals International Inc is abandoning its growth-by-acquisitions strategy for the time being to try to reduce debt, boost its stock price and one day return to its traditional deal-making More...
Israel’s Immune Pharmaceuticals to Issue New Stock
Israel’s Immune Pharmaceuticals Inc., a clinical stage biopharmaceutical company that engages in the development and commercialization of targeted therapeutics for the treatment of inflammatory diseases More...
Ackman supports Allergan’s $66 billion sale to Actavis
– Activist investor William “Bill” Ackman said on Tuesday he supports the $66 billion deal in which Actavis PLC will buy Allergan Inc and will withdraw his request for an Allergan special shareholder More...